2009
DOI: 10.1111/j.1365-4632.2009.04319.x
|View full text |Cite
|
Sign up to set email alerts
|

Severe aphthous stomatitis associated with oral calcineurin and mTOR inhibitors

Abstract: Since these drugs are used widely in the pediatric transplantation population, this report serves to heighten awareness of this debilitating phenomenon, and to stress the importance of exercising caution when sirolimus and tacrolimus are administered in combination to pediatric patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
5
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 11 publications
1
5
0
Order By: Relevance
“…Two participants had oral ulcers at the time of examination, and we found a positive relationship with the use of everolimus. Such a relationship has already been described elsewhere 36–39 . In this study, five patients were on everolimus and two of them had oral ulcers at the moment of clinical examination.…”
Section: Discussionsupporting
confidence: 76%
“…Two participants had oral ulcers at the time of examination, and we found a positive relationship with the use of everolimus. Such a relationship has already been described elsewhere 36–39 . In this study, five patients were on everolimus and two of them had oral ulcers at the moment of clinical examination.…”
Section: Discussionsupporting
confidence: 76%
“…Oral infections have been attributed to almost all immunosuppressive drugs [see, for example, papers (Habib et al , 2010; Mawardi et al , 2010; Sasaoka et al , 2010; Weng et al , 2011) regarding sirolimus, tacrolimus, everolimus, and mycophenolate mofetil, respectively].…”
Section: Oral Infectionsmentioning
confidence: 99%
“…Oral infections, reported since the 1970s (Greenberg and Cohen, 1977; Tyldesley et al , 1979), occur mainly during phases 1 and 2 and may present with ulceration that may be aphthous‐like and may be due to infections or drugs (including immunosuppressive agents such as sirolimus or other mTOR inhibitors) (Formica et al , 2003; Mahé et al , 2005; Chuang and Langone, 2007). They have been attributed to almost all immunosuppressive drugs [see, for example, papers (Habib et al , 2010; Mawardi et al , 2010; Sasaoka et al , 2010; Weng et al , 2011) regarding sirolimus, tacrolimus, everolimus, and mycophenolate mofetil, respectively]. Symptoms include discomfort and pain, which can be so severe as to impair eating, with consequent malnourishment and require local anesthetic applications (López‐Pintor et al , 2009; Vermeulen et al , 2010).…”
Section: Oral Infectionsmentioning
confidence: 99%
“…1,3,10,17 Oral ulcerations and stomatitis have been considered a possible post-transplantation complication due to immunosuppressives such as tacrolimus, everolimus, and mycophenolate mofetil (MMF), however the reports on this topic are controversial. [18][19][20][21] An additional side effect of CsA is gingival enlargement, which usually appears within the first 3 months, affects the interdental papillae in the anterior region, while does not appear to affect edentulous areas. Gingival enlargement prevents the maintenance of the oral hygiene causing an increased susceptibility to caries, periodontal diseases, and infections.…”
Section: Oral Manifestations In Solid Organ Transplant Recipientsmentioning
confidence: 99%